Scarica l'app Stockscreener
1.195
1.68%
0.005
Precedente Chiudi:
$1.19
Aprire:
$1.21
Volume 24 ore:
25,170
Relative Volume:
0.04
Capitalizzazione di mercato:
$29.80M
Reddito:
-
Utile/perdita netta:
$-10.21M
Rapporto P/E:
-2.0455
EPS:
-0.5842
Flusso di cassa netto:
-
1 W Prestazione:
+3.42%
1M Prestazione:
-0.82%
6M Prestazione:
+14.15%
1 anno Prestazione:
+7.08%
Intervallo 1D:
$1.18
$1.23
Intervallo di 1 settimana:
$1.12
$1.27
Portata 52W:
$0.80
$2.60
Neurosense Therapeutics Ltd Stock (NRSN) Company Profile
Nome
Neurosense Therapeutics Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Confronta NRSN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NRSN
Neurosense Therapeutics Ltd
|
1.19 | 29.80M | 0 | -10.21M | 0 | -0.5842 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.75 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.73 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.86 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
800.40 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.15 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Neurosense Therapeutics Ltd Borsa (NRSN) Ultime notizie
How NeuroSense Therapeutics Ltd. Equity Warrant stock performs in stagflationWeekly Stock Report & Free High Return Stock Watch Alerts - newser.com
What institutional flow reveals about NeuroSense Therapeutics Ltd.Quarterly Investment Review & Weekly Breakout Stock Alerts - newser.com
Is it too late to sell NeuroSense Therapeutics Ltd.Trade Signal Summary & Daily Technical Forecast Reports - newser.com
Using R and stats models for NeuroSense Therapeutics Ltd. Equity Warrant forecasting2025 Top Gainers & Community Verified Swing Trade Signals - newser.com
Historical volatility pattern of NeuroSense Therapeutics Ltd. Equity Warrant visualizedMarket Rally & Advanced Technical Signal Analysis - newser.com
Can a trend reversal in NeuroSense Therapeutics Ltd. lead to recoveryTrade Exit Report & Weekly Stock Breakout Alerts - newser.com
How sentiment analysis helps forecast NeuroSense Therapeutics Ltd. Equity WarrantSwing Trade & Reliable Intraday Trade Plans - newser.com
Will NeuroSense Therapeutics Ltd. stock return to pre crisis levelsJuly 2025 Volume & Daily Stock Trend Watchlist - newser.com
Using economic indicators to assess NeuroSense Therapeutics Ltd. Equity Warrant potentialWeekly Trade Review & Daily Chart Pattern Signal Reports - newser.com
Using data filters to optimize entry into NeuroSense Therapeutics Ltd.Weekly Stock Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
Can NeuroSense Therapeutics Ltd. Equity Warrant rally from current levelsTrade Analysis Summary & Safe Entry Point Identification - newser.com
Real time scanner hits for NeuroSense Therapeutics Ltd. explained2025 Risk Factors & Long-Term Safe Investment Plans - newser.com
Will NeuroSense Therapeutics Ltd. (H1Z) stock draw ESG focused fundsInsider Selling & Free Daily Entry Point Trade Alerts - newser.com
Backtesting results for NeuroSense Therapeutics Ltd. trading strategiesTrade Signal Summary & AI Forecasted Entry/Exit Points - newser.com
NeuroSense Therapeutics Ltd. stock momentum explainedInsider Selling & Stock Portfolio Risk Management - newser.com
NeuroSense Therapeutics (NASDAQ:NRSN) Shares Down 1.7% – Time to Sell? - Defense World
NeuroSense: PrimeC Produces Statistically Significant Reductions in Alzheimer's Disease Biomarkers - Sahm
Why NeuroSense Therapeutics Ltd. (H1Z) stock attracts wealthy investorsJuly 2025 Volume & Consistent Growth Equity Picks - newser.com
NeuroSense Announces Promising Alzheimer’s Biomarker Reductions with PrimeC - TipRanks
Neurosense Therapeutics LtdPrimeC produces statistically significant reductions in Alzheimer's disease biomarkers - MarketScreener
Volume spikes in NeuroSense Therapeutics Ltd. stock – what they meanPortfolio Risk Summary & Risk Controlled Daily Trade Plans - newser.com
Heatmap analysis for NeuroSense Therapeutics Ltd. Equity Warrant and competitorsPrice Action & Daily Oversold Stock Bounce Ideas - newser.com
Will NeuroSense Therapeutics Ltd. stock continue dividend increasesJuly 2025 Closing Moves & Safe Capital Growth Stock Tips - newser.com
Why NeuroSense Therapeutics Ltd. stock is rated strong buyMarket Activity Report & Daily Profit Focused Screening - newser.com
Is NeuroSense Therapeutics Ltd. (H1Z) stock undervalued after correctionInsider Selling & High Win Rate Trade Tips - newser.com
Published on: 2025-10-05 05:10:08 - newser.com
Will NeuroSense Therapeutics Ltd. Equity Warrant stock maintain dividend yieldJuly 2025 Review & Daily Chart Pattern Signals - newser.com
Leading vs lagging indicators on NeuroSense Therapeutics Ltd. Equity Warrant performanceEarnings Risk Report & High Yield Stock Recommendations - newser.com
Published on: 2025-10-05 02:56:57 - newser.com
NeuroSense Reports Positive Initial Results for Alzheimer’s Drug Candidate - MSN
Why hedge funds are buying NeuroSense Therapeutics Ltd. Equity Warrant stock2025 Historical Comparison & Momentum Based Trading Signals - newser.com
Is NeuroSense Therapeutics Ltd. Equity Warrant stock undervalued vs historical averagesTrade Analysis Summary & Safe Capital Growth Tips - newser.com
Published on: 2025-10-03 05:13:43 - newser.com
Why NeuroSense Therapeutics Ltd. (H1Z) stock is a must watch tickerJuly 2025 Fed Impact & Real-Time Chart Pattern Alerts - newser.com
Published on: 2025-10-02 23:30:57 - newser.com
Neurosense Therapeutics Ltd Azioni (NRSN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.07%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):